Large cell neuroendocrine carcinoma of the endometrium: A case report and literature review

Taiwan J Obstet Gynecol. 2018 Feb;57(1):144-149. doi: 10.1016/j.tjog.2017.12.025.

Abstract

Objective: To report a case and review published cases of large cell neuroendocrine carcinoma (LCNEC) of the endometrium.

Case report: A 51-year-old female presented with postmenopausal bleeding and a palpable pelvic mass. An endometrial biopsy showed a malignant mixed Mullerian tumor (MMMT). Suboptimal debulking surgery was performed. The final pathology revealed stage IVB endometrial LCNEC. Post-operative adjuvant chemotherapy with cisplatin and etoposide was administered. Two months after discontinuing adjuvant chemotherapy, salvage chemotherapy with cisplatin and ifosfamide was administered due to tumor progression; however, obstructive ileus was noted 2 months later. A segmental small bowel resection and palliative colostomy were performed. She died secondary to a post-operative infection 8 days after the operation.

Conclusion: Endometrial LCNEC is a rare but aggressive disease. If diagnosed, combined therapies, including staging surgery, following by adjuvant radiotherapy and chemotherapy, should be performed.

Keywords: Chemotherapy; Endometrium; Neuroendocrine carcinoma; Radiotherapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Large Cell / drug therapy
  • Carcinoma, Large Cell / pathology*
  • Carcinoma, Large Cell / surgery
  • Carcinoma, Neuroendocrine / drug therapy
  • Carcinoma, Neuroendocrine / pathology*
  • Carcinoma, Neuroendocrine / surgery
  • Chemotherapy, Adjuvant
  • Cisplatin / therapeutic use
  • Combined Modality Therapy
  • Endometrial Neoplasms / drug therapy
  • Endometrial Neoplasms / pathology*
  • Endometrial Neoplasms / surgery
  • Endometrium / pathology
  • Etoposide / therapeutic use
  • Female
  • Humans
  • Middle Aged
  • Salvage Therapy / methods

Substances

  • Etoposide
  • Cisplatin